Mesa Laboratories continues to manufacture high accuracy dialysate meters and contribute toward the effective treatment of kidney disease. Mesa strives to be at the forefront of the dialysis industry and is always supporting advancements in the research and treatment of kidney disease. New legislation toward the continued progression of the kidney treatment community continues to be beneficial, as evidenced in the recent news below.
Reps Tom Marino (R-Pa.) and John Lewis (D-Ga.) have introduced “The Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4814),” a bill that supports improvements in the research, treatment, and care of chronic kidney disease.
“This bill is important because it provides a blueprint for the future of the ESRD program” said Dr. Ed Jones, chairman of Kidney Care Partners and a practicing nephrologist. “By supporting coordinated research programs, greater patient choice, and economic stability, this legislation would strengthen the delivery of care for millions of Americans living with kidney disease.”
According to Kidney Care Partners, “The Chronic Kidney Disease Improvement in Research and Treatment Act” would do the following:
1. Improve understanding of kidney disease.
2. Improve beneficiary access to treatments for kidney disease.
3. Expand patient choice and improve the coordination of care.
“The kidney community applauds Representatives Marino and Lewis for their long-time leadership and ongoing efforts to protect our nation’s most vulnerable patient population, and we look forward to working with Congress to advance this important legislation,” added Dr. Jones. “The Chronic Kidney Disease Improvement in Research and Treatment Act ensures that individuals with kidney disease have the tools, resources, and care they need to live life to the fullest today and into the future.”
To view the full article on the Chronic Kidney Disease see the link below.
For more information on Mesa Labs DialyGuard products, visit http://dialyguard.mesalabs.com/